Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Aspen Aesthetics dba Fifty 410
WARNING LETTER
•Aspen Aesthetics dba Fifty 410•December 31, 2025

Aspen Aesthetics dba Fifty 410 – FDA Warning Letter, Dec 31, 2025

Record Details

The FDA issued a Warning Letter to Aspen Aesthetics, operating as Fifty 410, on February 20, 2026, following a December 2025 review of their website. The agency found that Fifty 410 offered misbranded compounded semaglutide and tirzepatide drug products. Key violations included false and misleading claims on their website. Specifically, the company's website falsely suggested that Fifty 410 was the compounder of these drugs, which was incorrect. Additionally, the claim "clinically proven ingredients" for these compounded products was deemed misleading because compounded drugs are not FDA-approved and have not been evaluated for safety and effectiveness in the same way as approved drugs. These actions constitute misbranding under sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act (FDCA), and the introduction of such misbranded products into interstate commerce violates section 301(a) of the FDCA. The FDA requires Fifty 410 to take immediate action. Within fifteen working days, the company must provide a written response outlining specific steps taken to address these violations, including identifying the actual compounders, providing product labeling, and either modifying or removing the misleading website claims. Failure to comply may result in further legal action.

Company
Aspen Aesthetics dba Fifty 410
Inspection date
December 31, 2025
Product type
drugs
Office
Center for Drug Evaluation and Research
Person
  • Matthew J. Lash (Acting Director)
View Company Profile

ID · eedcdda0-7806-44d2-8ea9-ad0efb821257

Violation Codes10
21 U.S.C. 321(p)21 U.S.C. 331(c)FD&C Act 503AFD&C Act 201(g)21 CFR 201.61(a)FD&C Act 503B(A)(10)(A)(i)FD&C Act 301(c)21 U.S.C. 352(a)FD&C Act 503(b)FD&C Act 201(p)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Aspen Aesthetics dba Fifty 410
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.